Lista de obras - Jordan Hansford - Dominio Público Uruguay

A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor

scientific article published on 01 July 2019

A unique case of refractory primary mediastinal B-cell lymphoma with JAK3 mutation and the role for targeted therapy

artículo científico publicado en 2014

Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas

scientific article published on 25 September 2019

Carboplatin Hypersensitivity Reactions in Pediatric Low Grade Glioma Are Protocol Specific and Desensitization Shows Poor Efficacy.

artículo científico publicado en 2015

Central Diabetes Insipidus and Cisplatin-Induced Renal Salt Wasting Syndrome: A Challenging Combination.

artículo científico publicado en 2016

Clinical Management and Tumor Surveillance Recommendations of Inherited Mismatch Repair Deficiency in Childhood

artículo científico publicado en 2017

Correction to: International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma

artículo científico publicado en 2019

DIPG-69. CHARACTERISTICS OF PATIENTS ≥ 10 YEARS OF AGE WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY

DNA methylation-based classification of central nervous system tumours.

artículo científico publicado en 2018

Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation.

artículo científico publicado en 2016

EMBR-17. PINEOBLASTOMA SEGREGATES INTO MOLECULAR SUBTYPES WITH DISTINCT CLINICOPATHOLOGIC FEATURES: REPORT FROM THE RARE BRAIN TUMOR CONSORTIUM

Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study

artículo científico publicado en 2019

Efficacy of acute myeloid leukemia therapy without stem-cell transplantation in a child with blastic plasmacytoid dendritic cell neoplasm.

artículo científico publicado en 2013

Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer Susceptibility.

artículo científico publicado en 2016

Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency

artículo científico publicado en 2022

HG-53HYPERMUTATION AND NEOANTIGEN FORMATION PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION IN CHILDHOOD BIALLELIC MISMATCH REPAIR DEFICIENT GLIOBLASTOMA.

artículo científico publicado en 2016

HGG-20. DNA METHYLATION ANALYSIS OF HIGH-GRADE GLIOMA IN PATIENTS WITH MISMATCH REPAIR DEFICIENCIES

Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis

artículo científico publicado en 2020

Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapy

artículo científico publicado en 2012

In utero and early postnatal presentation of autoimmune lymphoproliferative syndrome in a family with a novel FAS mutation

artículo científico publicado en 2012

Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors

artículo científico publicado en 2016

International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma

artículo científico publicado en 2018

LG-15RISK ASSESSMENT IN PAEDIATRIC GLIOMA - TIME TO MOVE ON FROM THE BINARY CLASSIFICATION.

artículo científico publicado en 2016

LGG-59. REMARKABLE OBJECTIVE RESPONSE AND FAVORABLE SURVIVAL FOR BRAF-V600E CHILDHOOD LOW-GRADE GLIOMAS TO BRAF INHIBITORS COMPARED CONVENTIONAL CHEMOTHERAPY

artículo científico publicado en 2018

Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive

artículo científico publicado en 2015

Low rates of recurrence and slow progression of pediatric pilocytic astrocytoma after gross-total resection: justification for reducing surveillance imaging.

artículo científico publicado en 2016

MBCL-51. RETROSPECTIVE ANALYSIS OF VICTORIAN PATIENTS DIAGNOSED WITH MEDULLOBLASTOMA BETWEEN 1990-2017 ⬇️

Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.

artículo científico publicado en 2013

Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features.

artículo científico publicado en 2018

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)

artículo científico publicado en 2021

PNR-05PRIMITIVE MYXOID MESENCHYMAL TUMOUR OF INFANCY – A CASE OF EARLY CHEMOTHERAPY-RESPONSIVENESS AND REVIEW OF THE LITERATURE.

artículo científico publicado en 2016

PNR-33MOLECULAR RE-EVALUATION OF INSTITUTIONALLY DIAGNOSED CNS-PNETS: CLINICAL CONSEQUENCES OF CONFINED DIAGNOSTIC GROUPS.

artículo científico publicado en 2016

PNR-39DISTINCT GENE FUSIONS SEGREGATE SUB-CLASSES OF CNS-PNETs.

artículo científico publicado en 2016

PNR-40EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES: A UNIQUE NEW CLINICAL ENTITY.

artículo científico publicado en 2016

Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma

artículo científico publicado en 2020

Personalised medicine in paediatric oncology: Ethical practice outside the clinical trial framework?

artículo científico publicado en 2018

Recurrent SPECC1L-NTRK fusions in paediatric sarcoma and brain tumours

artículo científico publicado en 2020

Reply to Comment on: Carboplatin Hypersensitivity Reactions in Pediatric Low Grade Glioma Are Protocol Specific and Desensitization Shows Poor Efficacy.

artículo científico publicado en 2015

Report of a bi-allelic truncating germline mutation in TP53

artículo científico publicado en 2019

Risk assessment in paediatric glioma-Time to move on from the binary classification.

artículo científico publicado en 2017

Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy

artículo científico

Spinal Cord Hyperintensities in Neurofibromatosis Type 1: Are They the Cord Equivalent of Unidentified Bright Objects in the Brain?

artículo científico publicado en 2018

The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants

artículo científico publicado en 2016

Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q

artículo científico publicado en 2021

Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma

artículo científico publicado en 2018

Lista de obras de Jordan Hansford

A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor

A unique case of refractory primary mediastinal B-cell lymphoma with JAK3 mutation and the role for targeted therapy

Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas

Carboplatin Hypersensitivity Reactions in Pediatric Low Grade Glioma Are Protocol Specific and Desensitization Shows Poor Efficacy.

Central Diabetes Insipidus and Cisplatin-Induced Renal Salt Wasting Syndrome: A Challenging Combination.

Clinical Management and Tumor Surveillance Recommendations of Inherited Mismatch Repair Deficiency in Childhood

Correction to: International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma

DIPG-69. CHARACTERISTICS OF PATIENTS ≥ 10 YEARS OF AGE WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY

DNA methylation-based classification of central nervous system tumours.

Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation.

EMBR-17. PINEOBLASTOMA SEGREGATES INTO MOLECULAR SUBTYPES WITH DISTINCT CLINICOPATHOLOGIC FEATURES: REPORT FROM THE RARE BRAIN TUMOR CONSORTIUM

Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study

Efficacy of acute myeloid leukemia therapy without stem-cell transplantation in a child with blastic plasmacytoid dendritic cell neoplasm.

Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer Susceptibility.

Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency

HG-53HYPERMUTATION AND NEOANTIGEN FORMATION PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION IN CHILDHOOD BIALLELIC MISMATCH REPAIR DEFICIENT GLIOBLASTOMA.

HGG-20. DNA METHYLATION ANALYSIS OF HIGH-GRADE GLIOMA IN PATIENTS WITH MISMATCH REPAIR DEFICIENCIES

Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis

Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapy

In utero and early postnatal presentation of autoimmune lymphoproliferative syndrome in a family with a novel FAS mutation

Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors

International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma

LG-15RISK ASSESSMENT IN PAEDIATRIC GLIOMA - TIME TO MOVE ON FROM THE BINARY CLASSIFICATION.

LGG-59. REMARKABLE OBJECTIVE RESPONSE AND FAVORABLE SURVIVAL FOR BRAF-V600E CHILDHOOD LOW-GRADE GLIOMAS TO BRAF INHIBITORS COMPARED CONVENTIONAL CHEMOTHERAPY

Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive

Low rates of recurrence and slow progression of pediatric pilocytic astrocytoma after gross-total resection: justification for reducing surveillance imaging.

MBCL-51. RETROSPECTIVE ANALYSIS OF VICTORIAN PATIENTS DIAGNOSED WITH MEDULLOBLASTOMA BETWEEN 1990-2017 ⬇️

Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.

Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features.

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)

PNR-05PRIMITIVE MYXOID MESENCHYMAL TUMOUR OF INFANCY – A CASE OF EARLY CHEMOTHERAPY-RESPONSIVENESS AND REVIEW OF THE LITERATURE.

PNR-33MOLECULAR RE-EVALUATION OF INSTITUTIONALLY DIAGNOSED CNS-PNETS: CLINICAL CONSEQUENCES OF CONFINED DIAGNOSTIC GROUPS.

PNR-39DISTINCT GENE FUSIONS SEGREGATE SUB-CLASSES OF CNS-PNETs.

PNR-40EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES: A UNIQUE NEW CLINICAL ENTITY.

Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma

Personalised medicine in paediatric oncology: Ethical practice outside the clinical trial framework?

Recurrent SPECC1L-NTRK fusions in paediatric sarcoma and brain tumours

Reply to Comment on: Carboplatin Hypersensitivity Reactions in Pediatric Low Grade Glioma Are Protocol Specific and Desensitization Shows Poor Efficacy.

Report of a bi-allelic truncating germline mutation in TP53

Risk assessment in paediatric glioma-Time to move on from the binary classification.

Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy

Spinal Cord Hyperintensities in Neurofibromatosis Type 1: Are They the Cord Equivalent of Unidentified Bright Objects in the Brain?

The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants

Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q

Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma